BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 28796572)

  • 1. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
    Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
    Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
    Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
    Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
    Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
    J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
    Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
    Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
    Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site.
    Plumitallo S; Ruiz-Llorente L; Langa C; Morini J; Babini G; Cappelletti D; Scelsi L; Greco A; Danesino C; Bernabeu C; Olivieri C
    Gene; 2018 Mar; 647():85-92. PubMed ID: 29305977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
    Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
    BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia.
    Duerig I; Pylaeva E; Ozel I; Wainwright S; Thiel I; Bordbari S; Domnich M; Siakaeva E; Lakomek A; Toppe F; Schleupner C; Geisthoff U; Lang S; Droege F; Jablonska J
    J Leukoc Biol; 2023 Nov; 114(6):639-650. PubMed ID: 37555392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
    Ardelean DS; Letarte M
    Front Genet; 2015; 6():35. PubMed ID: 25717337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
    Sabbà C; Pasculli G; Lenato GM; Suppressa P; Lastella P; Memeo M; Dicuonzo F; Guant G
    J Thromb Haemost; 2007 Jun; 5(6):1149-57. PubMed ID: 17388964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.